Dare Bioscience, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for DARE, updated each market day.
DARE AI Sentiment
AI predicts Dare Bioscience, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Dare Bioscience, Inc. Common Stock
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
Sector
Exchange
Market Cap
$26,935,078
Cap Tier
Employees
24
Headquarters
SAN DIEGO, CA
Listed Since
April 10, 2014
Website
DARE Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
DARE Volatility
Dare Bioscience, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
